Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea · Delayed Price · Currency is KRW 6,340.00
-590.00 (-8.51%)
Oct 12, 2026, 3:30 PM KST
Hyundai Bioscience Market Cap
Hyundai Bioscience has a market cap or net worth of 611.83 billion as of October 12, 2026. It is the 15,211th most valuable company in the world and the 409th biggest in South Korea. Its market cap has increased by 19.98% in one year.
Market Cap
611.83B
Enterprise Value
592.05B
Revenue
3.32B
Global Rank
Country Rank
#409 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 611.83B, an increase of 1,188.23%. That is a compound annual growth rate of 11.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 611.83B | 28.31% |
| Dec 30, 2025 | 476.83B | -15.13% |
| Dec 30, 2024 | 561.85B | -45.92% |
| Dec 28, 2023 | 1.04T | -4.44% |
| Dec 29, 2022 | 1.09T | 11.39% |
| Dec 30, 2021 | 976.10B | -6.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Komipharm International | 821.80B |
| Pharmicell | 771.65B |
| Chabiotech | 758.52B |
| Onconic Therapeutics | 675.21B |
| GI Innovation | 545.81B |
| AbClon | 509.78B |
| Proteina | 489.96B |
| GC Corp. | 443.05B |